Akut mieloid leukémia (AML): vizsgálatok itt: Olaszország
61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisLeállítva(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Bologna, Florence, Salerno, Verona
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Bologna, Meldola, Milan
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Ancona, Bologna, Civitanova Marche, Milan, Palermo, Perugia, Pescara, Rome, Salerno, Trieste, Turin
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 1. fázisTaking peopleSafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Bologna, Ravenna, Rome
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06001788 · EU 2023-510288-37-00 - 2/3. fázisTaking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Bologna, Florence, Meldola, Ravenna, Rome, Rozzano
- Életkor
- 18 év to 80 év
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - 2. fázisNot yet taking people in OlaszországRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Bologna, Monza, Naples, Padova, Rome
- Életkor
- Up to 64 év
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00 - 2. fázisCsak meghívásosA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1/2. fázisNot yet taking people in OlaszországStudy testing a new experimental cell therapy in adults and children With Relapsed or Refractory Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm
- Where
- Bergamo, Monza
- People
- 18
- Run by
- Fondazione Tettamanti
See details and how to join2025-524977-18-00 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Bologna, Rome
- Életkor
- Up to 17 év
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - 1/2. fázisNot yet taking people in OlaszországA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Bologna, Naples, Padova, Pavia, Rozzano
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - No phaseTaking peopleObservational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
- Where
- Florence
- Életkor
- 18 év and over
- People
- 220
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT07080970 - 2. fázisTaking peopleA Phase II, Open-Label Randomized Study of Intravenous Tambiciclib in Combination with the Standard of care Venetoclax and Azacitidine in Patients with Newly Diagnosed AML Who Failed to Achieve at Least MLFS After the First Two Cycles of Treatment with Venetoclax and Azacitidine Alone
- Where
- Castelfranco Veneto, Genoa, Meldola, Naples, Ravenna
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
See details and how to join2025-524308-31-00 - No phaseTaking peopleDecoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
- Where
- Milan, Reggio Calabria
- Életkor
- 18 év and over
- People
- 80
- Run by
- Ciceri Fabio
See details and how to joinNCT06535113 - 3. fázisFut, nem toborozAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Bari, Bergamo, Bologna, Brescia, Florence, Meldola, Milan, Perugia, Pesaro, Udine, Venice
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00 - No phaseTaking peopleNext Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
- Where
- Brescia
- People
- 20
- Run by
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
See details and how to joinNCT03058588 - No phaseTaking peopleDesign and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial
- Where
- Brescia
- Életkor
- 18 év to 75 év
- People
- 1941
- Run by
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
See details and how to joinNCT07420790 - 2. fázisNot yet taking people in OlaszországMatched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia
- Where
- Perugia, Pescara
- Életkor
- 18 év to 70 év
- People
- 28
- Run by
- Antonio Pierini
See details and how to joinNCT07552649 - 2. fázisTaking peopleA phase 2A pilot study to assess the safety and efficacy of eltanexor in relapsed/refractory NPM1-mutated acute myeloid leukemia
- Where
- Ancona, Catania, Perugia
- Életkor
- 18 év and over
- People
- 10
- Run by
- Azienda Ospedaliero Universitaria Delle Marche
See details and how to join2024-514724-16-01 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome, Turin
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleCorrelation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.
- Where
- Pavia
- People
- 14
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07254312 - 3. fázisTaking peopleA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
- Where
- Lecce, Meldola, Pisa, Rome, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 486 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06389292 · EU 2024-516436-10-00 - 3. fázisNot yet taking people in OlaszországIvosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Where
- Bologna, Milan, Roma, Torino
- Életkor
- 18 év and over
- People
- 227 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07075016 - No phaseTaking peopleObservational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
- Where
- San Giovanni Rotondo, Sassari
- Életkor
- 18 év and over
- People
- 397
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06513273 - No phaseTaking peopleAnalysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
- Where
- Milan
- Életkor
- 18 év and over
- People
- 500
- Run by
- Ciceri Fabio
See details and how to joinNCT05124288 - 2. fázisFut, nem toborozAnti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
- Where
- Genoa, Rozzano
- Életkor
- 18 év to 99 év
- People
- 42
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT06892223 · EU 2024-516974-31-00